MicroRNA Signatures in Blood or Bone Marrow Distinguish Subtypes of Pediatric Acute Lymphoblastic Leukemia
2020 · Translational Oncology · 16 citations
https://doi.org/10.1016/j.tranon.2020.100800
P
Pallavi Kumari
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
57
Papers
127
Citations
6
h-index
5
i10-index
Pallavi Kumari is an academic researcher from Centre of Polymer and Carbon Materials. The author has contributed to research in topics: Cancer Genomics and Diagnostics & Nanoparticle-Based Drug Delivery & Protein Degradation and Inhibitors. The author has an h-index of 6, co-authored 49 publications.
ORCID: 0000-0002-0722-2023Papers by this author
worksCerium oxide nanoparticles prepared through Bio-combustion using Ficus carica as effective antioxidant, anticancer and dye degrading agent
2025 · Scientific Reports · 9 citations
https://doi.org/10.1038/s41598-025-13914-3
Evaluation of Enhanced Cytotoxicity Effect of Repurposed Drug Simvastatin/Thymoquinone Combination against Breast Cancer Cell Line
2023 · Cardiovascular & Hematological Agents in Medicinal Chemistry · 5 citations
https://doi.org/10.2174/0118715257259037231012182741
168P Biosimulation coupled with personalized tumor microenvironment (TME) modeling predicts response to immunotherapy treatment in NSCLC patients
2024 · Annals of Oncology · 0 citations
https://doi.org/10.1016/j.annonc.2024.08.2173
P2.06.17 Cellular Heterogeneity and Tertiary Lymphoid Structure Dynamics Predict Overall Survival in Immune Checkpoint Therapy-Treated NSCLC Patients
2025 · Journal of Thoracic Oncology · 0 citations
https://doi.org/10.1016/j.jtho.2025.09.551
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat